Genetic Data From Over 20,000 U.S. Children Misused for ‘Race Science’
By Mike McIntire,
The New York Times
| 01. 24. 2026
The National Institutes of Health failed to protect brain scans that an international group of fringe researchers used to argue for the intellectual superiority of white people.
Genetic researchers were seeking children for an ambitious, federally funded project to track brain development — a study that they told families could yield invaluable discoveries about DNA’s impact on behavior and disease.
They also promised that the children’s sensitive data would be closely guarded in the decade-long study, which got underway in 2015. Promotional materials included a cartoon of a Black child saying it felt good knowing that “scientists are taking steps to keep my information safe.”
The scientists did not keep it safe.
A group of fringe researchers thwarted safeguards at the National Institutes of Health and gained access to data from thousands of children. The researchers have used it to produce at least 16 papers purporting to find biological evidence for differences in intelligence between races, ranking ethnicities by I.Q. scores and suggesting Black people earn less because they are not very smart.
Mainstream geneticists have rejected their work as biased and unscientific. Yet by relying on genetic and other personal data from the prominent project, known as the Adolescent Brain Cognitive Development Study, the researchers gave...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
